{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:23:49Z","timestamp":1791235429841,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["bpgastro.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.bpg.2013.06.014","type":"journal-article","created":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T06:10:53Z","timestamp":1380607853000},"page":"553-563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Liver abnormalities and endocrine diseases"],"prefix":"10.1016","volume":"27","author":[{"given":"Patrizia","family":"Burra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2013.06.014_bib1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/qjmed\/95.9.559","article-title":"The relationship between the thyroid gland and the liver","volume":"95","author":"Malik","year":"2002","journal-title":"QJM"},{"key":"10.1016\/j.bpg.2013.06.014_bib2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1055\/s-2008-1041234","article-title":"The neuromuscular effects of hypothyroidism","volume":"11","author":"Laycock","year":"1991","journal-title":"Semin Neurol"},{"key":"10.1016\/j.bpg.2013.06.014_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0010-4825(89)90035-8","article-title":"Value of clinical features for distinguishing myxedema ascites from other forms of ascites","volume":"19","author":"Kinney","year":"1989","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.bpg.2013.06.014_bib4","doi-asserted-by":"crossref","first-page":"927","DOI":"10.7326\/0003-4819-77-6-927","article-title":"Central congestive fibrosis of the liver in myxedema ascites","volume":"77","author":"Baker","year":"1972","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2013.06.014_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/archinte.1984.00350130143025","article-title":"Unusual manifestations of hypothyroidism","volume":"144","author":"Klein","year":"1984","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bpg.2013.06.014_bib6","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/hep.1840090225","article-title":"Thyroid hormones and the hepatic handling of bilirubin. I. Effects of hypothyroidism and hyperthyroidism on the hepatic transport of bilirubin mono- and diconjugates in the Wistar rat","volume":"9","author":"Van Steenbergen","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2013.06.014_bib7","first-page":"94","article-title":"Primary hypothyroidism","volume":"6","author":"Gaitan","year":"1997","journal-title":"Curr Ther Endocrinol Metab"},{"key":"10.1016\/j.bpg.2013.06.014_bib8","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/milmed\/143.8.548","article-title":"Abnormalities of liver function tests in tyrotoxicosis","volume":"143","author":"Thompson","year":"1978","journal-title":"Mil Med"},{"key":"10.1016\/j.bpg.2013.06.014_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/014107687807100307","article-title":"Serum enzyme disturbances in thyrotoxicosis and myxoedema","volume":"71","author":"Doran","year":"1978","journal-title":"J R Soc Med"},{"key":"10.1016\/j.bpg.2013.06.014_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1600-0676.1991.tb00516.x","article-title":"Liver changes in patients with hyperthyroidism","volume":"11","author":"Sola","year":"1991","journal-title":"Liver"},{"key":"10.1016\/j.bpg.2013.06.014_bib11","first-page":"1","article-title":"Hepatic dysfunction in hospitalized patients with acute thyrotoxicosis: a decade of experience","author":"Elias","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.bpg.2013.06.014_bib12","first-page":"1727","article-title":"Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned?","volume":"82","author":"Williams","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bpg.2013.06.014_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/000992289303200105","article-title":"Propylthiouracil hepatotoxicity. A review and case presentation","volume":"32","author":"Levy","year":"1993","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.bpg.2013.06.014_bib14","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/0002-9343(73)90258-1","article-title":"Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis","volume":"55","author":"Golding","year":"1973","journal-title":"Am J Med"},{"key":"10.1016\/j.bpg.2013.06.014_bib15","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/BF01311724","article-title":"Increased incidence of hypothyroidism in primary biliary cirrhosis","volume":"28","author":"Elta","year":"1983","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2013.06.014_bib16","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1478-3231.2009.02003.x","article-title":"Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease","volume":"29","author":"Silveira","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.bpg.2013.06.014_bib17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0168-8278(05)80228-4","article-title":"Latent autoimmune thyroid disease in patients with chronic HCV hepatitis","volume":"17","author":"Pateron","year":"1993","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2013.06.014_bib18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1440-1746.1995.tb01106.x","article-title":"Clinical associations between thyroid and liver diseases","volume":"10","author":"Huang","year":"1995","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2013.06.014_bib19","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/pgmj.68.804.804","article-title":"Severity of alcoholic liver disease and markers of thyroid and steroid status","volume":"68","author":"Burra","year":"1992","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.bpg.2013.06.014_bib20","first-page":"219","article-title":"The effects of ethanol, 3,5,3\u2032-triiodothyronine (T3) and oestradiol (E2) on thyroid hormone nuclear receptor expression in human hepatocyte primary cultures","volume":"30","author":"Burra","year":"1995","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.bpg.2013.06.014_bib21","first-page":"281","article-title":"Thyroxine-binding globulin in patients with chronic hepatitis B virus infection: different implications in hepatitis and hepatocellular carcinoma","volume":"85","author":"Huang","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2013.06.014_bib22","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF03349374","article-title":"Relations between serum levels of TSH, TBG, T4, T3, rT3 and various histologically classified chronic liver diseases","volume":"3","author":"L'Age","year":"1980","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.bpg.2013.06.014_bib23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00004836-200009000-00016","article-title":"The effects of hypothyroidism on liver status of cirrhotic patients","volume":"31","author":"Oren","year":"2000","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2013.06.014_bib24","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/thy.1997.7.891","article-title":"Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature","volume":"7","author":"Koh","year":"1997","journal-title":"Thyroid"},{"key":"10.1016\/j.bpg.2013.06.014_bib25","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1002\/hep.22347","article-title":"Hypothyroidism in patients with hepatocellular carcinoma treated by transarterial chemoembolization","volume":"47","author":"Flohr","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2013.06.014_bib26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/annonc\/mdm483","article-title":"Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib","volume":"19","author":"Tamaskar","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bpg.2013.06.014_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cld.2010.09.008","article-title":"Endocrine diseases and the liver","volume":"15","author":"Maheshwari","year":"2011","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.bpg.2013.06.014_bib28","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/0016-5085(95)90595-2","article-title":"Subclinical Addison's disease: a cause of persistent abnormalities in transaminase values","volume":"109","author":"Boulton","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2013.06.014_bib29","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.25573","article-title":"Adrenocortical dysfunction in liver disease: a systematic review","volume":"55","author":"Fede","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2013.06.014_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00134-005-0005-5","article-title":"Adrenal-exhaustion syndrome in patients with liver disease","volume":"32","author":"Marik","year":"2006","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bpg.2013.06.014_bib31","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jhep.2007.06.008","article-title":"Adrenal insufficiency in liver disease \u2013 what is the evidence?","volume":"47","author":"O'Beirne","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2013.06.014_bib32","first-page":"748","article-title":"11 Beta-hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease","volume":"76","author":"Stewart","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bpg.2013.06.014_bib33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2796.1993.tb00745.x","article-title":"Liver damage from low-dose oral contraceptives","volume":"234","author":"Lindgren","year":"1993","journal-title":"J Intern Med"},{"key":"10.1016\/j.bpg.2013.06.014_bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-2008-1040559","article-title":"Female sex steroids and cholestasis","volume":"7","author":"Kreek","year":"1987","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2013.06.014_bib35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.7326\/0003-4819-88-4-487","article-title":"Prevalence of intrahepatic cholestasis of pregnancy in Chile","volume":"88","author":"Reyes","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2013.06.014_bib36","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/archinte.1985.00360050197037","article-title":"Ultrasonography in the diagnosis and follow-up of hepatic sinusoidal dilatation","volume":"145","author":"Weinberger","year":"1985","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bpg.2013.06.014_bib37","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1530\/eje.1.01886","article-title":"Gonadal dysfunction in systemic diseases","volume":"152","author":"Karagiannis","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.bpg.2013.06.014_bib38","series-title":"Principles and practice of endocrinology and metabolism","first-page":"1870","article-title":"The liver and endoscrine function","author":"De Maria","year":"2000"},{"key":"10.1016\/j.bpg.2013.06.014_bib39","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0959-437X(98)80081-6","article-title":"Haemochromatosis: an inherited metal and toxicity syndrome","volume":"8","author":"Cox","year":"1998","journal-title":"Curr Opin Genet Dev"},{"issue":"15 Suppl. 2","key":"10.1016\/j.bpg.2013.06.014_bib40","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1002\/lt.21899","article-title":"Sexual dysfunction after liver transplantation","author":"Burra","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.bpg.2013.06.014_bib41","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/TP.0b013e3181e1f1f6","article-title":"Sexual dysfunction in chronic liver disease: is liver transplantation an effective cure?","volume":"89","author":"Burra","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.bpg.2013.06.014_bib42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/2042018811419157","article-title":"An endocrine perspective of nonalcoholic fatty liver disease (NAFLD)","volume":"2","author":"Lomonaco","year":"2011","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.bpg.2013.06.014_bib43","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1210\/jc.2005-1056","article-title":"Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance","volume":"91","author":"Pagano","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bpg.2013.06.014_bib44","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/hep.23270","article-title":"Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial","volume":"51","author":"Ratziu","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2013.06.014_bib45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bpg.2013.06.014_bib46","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1464-5491.2005.01582.x","article-title":"Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults","volume":"22","author":"Jimba","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.bpg.2013.06.014_bib47","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2013.06.014_bib48","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/hep.20140","article-title":"Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction","volume":"39","author":"Adams","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2013.06.014_bib49","first-page":"680","article-title":"Growth hormone, insulinlike growth factor-1, and insulin like growth factor binding proteins 1 and 3 in chronic liver disease","volume":"21","author":"Donaghy","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2013.06.014_bib50","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1507\/endocrj.EJ12-0322","article-title":"Essential roles of growth hormone (GH) and insulin-like growth factor-I (IGF-I) in the liver","volume":"59","author":"Takahashi","year":"2012","journal-title":"Endocr J"},{"key":"10.1016\/j.bpg.2013.06.014_bib51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12072-007-9007-4","article-title":"Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease","volume":"1","author":"Ichikawa","year":"2007","journal-title":"Hepatol Int"},{"key":"10.1016\/j.bpg.2013.06.014_bib52","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2003.08.002","article-title":"Polycystic ovary syndrome: syndrome XX?","volume":"14","author":"Sam","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.bpg.2013.06.014_bib53","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/EJE-09-0958","article-title":"Hemostatic abnormalities in endocrine and metabolic disorders","volume":"162","author":"Franchini","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.bpg.2013.06.014_bib54","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/er.2008-0024","article-title":"The metabolic syndrome","volume":"29","author":"Cornier","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bpg.2013.06.014_bib55","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1160\/TH07-11-0682","article-title":"Metabolic syndrome, haemostasis and thrombosis","volume":"99","author":"Alessi","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bpg.2013.06.014_bib56","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1055\/s-2007-1000372","article-title":"Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review","volume":"33","author":"Mina","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.bpg.2013.06.014_bib57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0002-9343(86)90158-0","article-title":"Prevalence and prognostic significance of hypercholesterolemia in men with hypertension. Prospective data on the primary screenees of the Multiple Risk Factor Intervention Trial","volume":"80","author":"Stamler","year":"1986","journal-title":"Am J Med"},{"key":"10.1016\/j.bpg.2013.06.014_bib58","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1592\/phco.24.6.584.34738","article-title":"Statins and liver toxicity: a meta-analysis","volume":"24","author":"de Denus","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bpg.2013.06.014_bib59","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0002-9149(02)02590-0","article-title":"Getting more people on statins","volume":"90","author":"Roberts","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.bpg.2013.06.014_bib60","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0002-9149(02)02355-X","article-title":"The liver and lovastatin","volume":"89","author":"Tolman","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.bpg.2013.06.014_bib61","first-page":"711","article-title":"Considerations for safe use of statins: liver enzyme abnormalities and muscle toxicity","volume":"83","author":"Gillett","year":"2011","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.bpg.2013.06.014_bib62","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1665-2681(19)31030-0","article-title":"The prevalence and clinical characteristics of glucose metabolism disorders in patients with liver cirrhosis. A prospective study","volume":"11","author":"Garc\u00eda-Compe\u00e1n","year":"2012","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.bpg.2013.06.014_bib63","doi-asserted-by":"crossref","first-page":"e49279","DOI":"10.1371\/journal.pone.0049279","article-title":"Metformin inhibits glutaminase activity and protects against hepatic encephalopathy","volume":"7","author":"Ampuero","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bpg.2013.06.014_bib64","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.2337\/diacare.22.12.2067","article-title":"Frequency of liver disease in type 2 diabetic patients treated with oral antidiabetic agents","volume":"22","author":"Jick","year":"1999","journal-title":"Diabetes Care"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691813001273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691813001273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T15:02:14Z","timestamp":1564239734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691813001273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1521691813001273"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2013.06.014","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver abnormalities and endocrine diseases","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2013.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}